Today: 15 April 2026
Nvidia stock rises as CEO flags China H200 licence progress; NVDA earnings date set
29 January 2026
2 mins read

Nvidia stock rises as CEO flags China H200 licence progress; NVDA earnings date set

New York, January 29, 2026, 09:38 EST — Regular session

NVIDIA shares climbed 1.6% to $191.52 early Thursday after CEO Jensen Huang revealed China is still finalising the licence for its H200 chip, the company’s second most powerful AI processor. “The actual license for H200 is being finalised,” Huang said to reporters in Taipei. Reuters also reported that China has approved ByteDance, Alibaba, and Tencent to purchase over 400,000 H200 chips, though no purchase orders have followed yet. Reuters

The headline matters as traders sift through which approvals actually unlock shipments and which merely add to the backlog. For Nvidia, a China “yes” under strict conditions could still translate into a trickle of deliveries.

Capex — spending on assets like data centers — is another key factor. Meta Platforms boosted its capex budget by 73% alongside a strong revenue forecast. Tesla announced plans to more than double its capital expenditure. Microsoft, however, slid after cloud revenue came in below expectations, Reuters reported. “Maybe a bit of de-risking going into the print,” said Adam Turnquist, chief technical strategist at LPL Financial. Reuters

Investors have swung Nvidia shares between customer budget concerns and export news, sometimes within the same hour. That volatility can make the stock twitchy, even on minimal updates.

Chip stocks opened mostly higher Thursday. Intel surged roughly 11%, and Micron climbed about 6%. The iShares Semiconductor ETF added close to 2.7%, while AMD held steady with little change.

The sector was already firing on all cylinders following Wednesday’s rally, fueled by strong earnings from Texas Instruments and a solid quarter from chip equipment maker ASML, Reuters reported. “Companies across the broader supply chain … are reporting that conditions are improving,” said Louise Dudley, a portfolio manager for global equities at Federated Hermes. Reuters

Nvidia grabbed attention after a report surfaced that it, along with Amazon and Microsoft, is in talks to invest as much as $60 billion in OpenAI. Reuters, citing The Information, said Nvidia’s potential share could reach $30 billion. Reuters couldn’t immediately verify the story; Amazon and Microsoft declined to comment. Nvidia and OpenAI didn’t respond outside regular business hours.

Big Tech earnings are shining a light on the cost of AI expansion, as these giants are also Nvidia’s biggest customers. Microsoft, Meta, Amazon, and Alphabet are projected to boost AI spending by roughly 30%, pushing the total past $500 billion by 2026, Reuters reported. “Like in the internet boom, the first-mover advantage doesn’t always win the marathon,” said David Wagner, head of equities at Aptus Capital Advisors. Reuters

Nvidia’s ties to China are sparking political scrutiny. A U.S. lawmaker accused the company of aiding Chinese AI firm DeepSeek in refining models that China’s military later deployed. In a letter, the lawmaker called for stricter licensing and enforcement. Nvidia pushed back, saying “it makes no sense for the Chinese military to depend on American technology.” Reuters

Nvidia plans to release its fiscal 2026 fourth-quarter results via webcast on Feb. 25 at 2 p.m. PT (5 p.m. ET), per its investor relations calendar. Investors will be watching closely for guidance on data-center demand, supply issues, and any updates concerning shipments to China, which could move the stock.

Stock Market Today

  • SPDR S&P Biotech ETF (XBI) Sees $195.6 Million Outflow, Shares Down 2.5%
    April 15, 2026, 12:00 PM EDT. The SPDR S&P Biotech ETF (XBI) reported a significant $195.6 million outflow this week, a 2.5% decline in shares outstanding from 91.68 million to 89.35 million units. XBI's share price stands at $83.63, between its 52-week low of $61.78 and high of $136.61. Key holdings showed mixed performance: Global Blood Therapeutics rose 0.2%, Karuna Therapeutics fell 0.7%, and ChemoCentryx remained steady. ETFs trade in units, which can be created or destroyed based on demand, affecting the buying or selling of the underlying assets. Large outflows like this often lead to selling of biotechnology stocks within the fund, potentially impacting their prices.

Latest article

Oklo Stock Jumps After Board Shake-Up as AI Nuclear Bet Heads Toward July Test

Oklo Stock Jumps After Board Shake-Up as AI Nuclear Bet Heads Toward July Test

15 April 2026
Oklo shares rose 11% Wednesday after the company expanded its board to 11 members and made several management changes. The moves come as Oklo pursues major nuclear projects, including a Meta-backed 1.2 GW deal in Ohio and a Department of Energy reactor deadline in Texas. Recent SEC filings showed insider stock sales, some pre-arranged and others for tax withholding. No U.S. advanced reactor developer has begun commercial power production.
Oracle Stock Jumps Again After Bloom Energy Deal and AI Push—but Risks Still Linger

Oracle Stock Jumps Again After Bloom Energy Deal and AI Push—but Risks Still Linger

15 April 2026
Oracle shares jumped 5.3% to $171.68 Wednesday morning, extending a rally after the company unveiled new AI features and expanded its fuel-cell partnership with Bloom Energy. Oracle agreed to procure up to 2.8 gigawatts of Bloom’s fuel-cell systems for data centers, with 1.2 GW already contracted. The stock had climbed 12.7% Monday and 4.7% Tuesday.
Allbirds Stock Soars as Shoe Brand Bets $50 Million on AI Compute Pivot

Allbirds Stock Soars as Shoe Brand Bets $50 Million on AI Compute Pivot

15 April 2026
Allbirds secured up to $50 million in senior secured convertible notes and will pivot to AI compute infrastructure after selling its footwear business to American Exchange Group for $39 million. Shares jumped to $10.10, up $7.61, after the announcement. The company plans to rename itself NewBird AI and use the funds to buy GPUs for a rental business. A May 18 shareholder vote will decide on the asset sale and charter changes.
Broadcom Jumps on Meta AI Chip Deal as Marvell Gets New Bull Call

Broadcom Jumps on Meta AI Chip Deal as Marvell Gets New Bull Call

15 April 2026
Broadcom shares rose 3.9% after Meta extended its chip partnership through 2029, with the first rollout phase exceeding 1 gigawatt of compute. Marvell gained 1.5% as Oppenheimer raised its price target to $170, citing strong data-center networking growth. Wall Street opened higher, with the S&P 500 near record levels amid easing inflation signals.
Nordea Bank stock slips after Q4 profit rise; dividend lifted and buybacks stay in focus
Previous Story

Nordea Bank stock slips after Q4 profit rise; dividend lifted and buybacks stay in focus

Microsoft stock slides 10% after earnings beat as Azure outlook, AI bill unsettle Wall Street
Next Story

Microsoft stock slides 10% after earnings beat as Azure outlook, AI bill unsettle Wall Street

Go toTop